Facebook Twitter LinkedIn Instagram Email Printer Google Plus

Health Innovation Journal

Access Will Become Commoditized

Providers’ strategic control and differentiation will shift to be based on experience, ease of use, and price.

Partner, Health and Life Sciences, Oliver Wyman
Partner, Health and Life Sciences, Oliver Wyman
Principal, Health & Life Sciences, Oliver Wyman
Engagement Manager, Health & Life Sciences, Oliver Wyman

And How Stakeholders Can, Literally, Save the World

Climate change will be the biggest impact on global health. The healthcare industry may not respond in time.

Director, Marsh & McLennan Advantage Insights
Partner, Health and Life Sciences, Oliver Wyman

Future Truths: Inevitable and Inspiring

The current supply of inpatient beds is far higher than what we need now, or even what we'll need a decade from now.

Partner, Health and Life Sciences, Oliver Wyman
Engagement Manager, Health and Life Sciences, Oliver Wyman
Partner, Health and Life Sciences, Oliver Wyman
Partner, Oliver Wyman Actuarial Consulting

Changes are already here, they're real, and we believe they'll scale quickly.

Partner, Health and Life Sciences, Oliver Wyman
Principal, Health & Life Sciences, Oliver Wyman
Partner, Digital, Oliver Wyman
Senior Consultant, Oliver Wyman

Physicians are best positioned to curtail the $265 billion wasted annually on unneeded care.

Global Head, Health Services, Oliver Wyman
Professor of Surgery and Health Policy, Johns Hopkins Medicine
Principal, Health and Life Sciences, Oliver Wyman

Insights in your inbox

Subscribe

In the next decade, incumbents and innovators vying for a different relationship with consumers will shape healthcare’s front end.

Former Partner, Health & Life Sciences, Oliver Wyman
Principal, Health & Life Sciences, Oliver Wyman

Disruption in healthcare will be driven by the power of its trapped – and highly exploitable – value.

Partner, Health and Life Sciences, Oliver Wyman
Former Partner, Health & Life Sciences, Oliver Wyman
Managing Partner, Americas, Oliver Wyman

How genetics can help cut treatment costs by getting prevention services to consumers most at risk.

Chief Operating Officer, Color Genomics, Inc

As one of the fastest-rising categories of healthcare costs, pharmaceuticals need to develop a metric that explains pricing.

Partner, Health & Life Sciences, Oliver Wyman
Principal, Health & Life Sciences, Oliver Wyman